|
|
Volumn 9, Issue 4, 2010, Pages 257-258
|
|
Kinase inhibitors attract attention as oral rheumatoid arthritis drugs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
FOSTAMATINIB;
PHOSPHOTRANSFERASE INHIBITOR;
COST EFFECTIVENESS ANALYSIS;
LICENSING;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SHORT SURVEY;
ADMINISTRATION, ORAL;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIALS AS TOPIC;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
HUMANS;
OXAZINES;
PROTEIN KINASE INHIBITORS;
PYRIDINES;
PYRIMIDINES;
PYRROLES;
|
|
EID: 77950487586
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3155 Document Type: Short Survey |
|
Times cited : (26)
|
|
References (0)
|
